Potential roles of gut microbiome and metabolites in modulating ALS in mice
#GLP1 #Obesity #Biotech #ClinicalTrials #Pharma #DrugSafety #MetabolicSovereignty #MolekuleIntel #DecisionVelocity #DrugDevelopment To view or add a comment, sign in Eli Lilly & Novo Nordisk Near Trump Deal on Obesity Drug Prices Eli Lilly and Novo Nordisk are close to finalizing a deal with the Trump administration that would slash the prices of their top-selling obesity drugs
What Women with Lipedema Need to Know About GLP-1s Like Ozempic and Mounjaro GLP-1 medications like Ozempic, Wegovy, and newer agents like tirzepatide (Mounjaro) are getting a lot of attention for weight lossbut what about lipedema
Kourtney Kardashian just launched an Ozempic style supplement - but experts are warning against taking it If it sounds too good to be true, it probably is
Indications in the market include Type 2 Diabetes at 5.0 to 20.0 USD Billion, Obesity at 3.0 to 12.0 USD Billion, and Cardiovascular Diseases at 2.77 to 10.0 USD Billion
These side effects are usually mild and tend to improve over time